Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Rheumatol Adv Pract ; 8(2): rkae061, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38827363

RESUMO

Objectives: We aimed to explore the radiographic definitions of types of New Bone formation (NBF) by focusing on the terminology, description and location of the findings. Methods: Three systematic literature reviews were conducted in parallel to identify the radiographic spinal NBF definitions for spondyloarthritis (SpA), Diffuse Idiopathic Skeletal Hyperostosis (DISH) and Osteorathritis (OA). Study characteristics and definitions were extracted independently by two reviewers. Definitions were analysed and collated based on whether they were unique, modified or established from previous research. Results: We identified 33 studies that indicated a definition for the NBF in SpA, 10 for DISH and 7 for spinal OA. In SpA, the variations in syndesmophytes included the description as well as the subtypes and locations. The differentiation of syndesmophytes from osteophytes were included in 12 articles, based on the origin and the angle of the NBF and associated findings. The definitions of DISH varied in the number of vertebrae, level and laterality. For OA, five articles indicated that osteophytes arose from the anterior or lateral aspects of the vertebral bodies, and two studies required a size cut-off. Discussion: Our ultimate aim is to create formal NBF definitions for SpA, DISH and OA guided by an atlas, through a Delphi exercise with international experts. The improved ability to differentiate these conditions radiographically will not only allow the clinicians to accurately approach patients but also will help the researchers to better classify patient phenotypes and focus on accurate radiographic outcomes.

2.
Eur Radiol ; 32(10): 6752-6758, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-35925385

RESUMO

OBJECTIVE: To investigate the diagnostic performance of preoperative MRI in evaluating posterolateral corner (PLC) structures after acute knee dislocation (KD) and determine the correlation of MRI with operative findings for grading structure integrity. METHODS: Acute knee (femorotibial) dislocations between 2005 and 2020 with preoperative MRI and surgical posterolateral corner repair were identified from a single academic institution. From MRI, integrity was evaluated for PLC structures: lateral collateral ligament (LCL), popliteus tendon (PT), biceps femoris tendon (BFT), and ligamento-capsular complex (LCC). Frequency of injury to each structure and number of PLC structures torn in each case were tabulated. Diagnostic performance of MRI was determined using surgery as the reference standard. Correlation between MRI and surgery for each PLC structure was determined using kappa. RESULTS: Thirty-nine KD cases (19 right) in 39 patients (28 male) were included, with mean age of 33 years. Mechanism of injury was as follows: high energy 52%, low energy 38%, ultra-low energy 10%. LCL was most frequently torn, in 95% (37/39) of cases. Most commonly, three of four PLC structures were torn in 54% (21/39) of cases. Diagnostic accuracy of MRI was high for LCL 95%, BFT 87%, PT 82%, and LCC 92%. Correlation between MRI and surgical findings was variable: substantial for BFT, moderate for LCL and PT, and fair for LCC. CONCLUSION: MRI has high accuracy for detecting tears of posterolateral corner stabilizers in the setting of acute KD. However, for grading structure integrity, the correlation of MRI with surgical findings is variable, ranging from fair to substantial. KEY POINTS: • In acute knee dislocation, MRI has high diagnostic accuracy for detecting tears of posterolateral corner (PLC) structures. • Preoperative MRI should be considered by orthopedic surgeons when there is clinical concern for posterolateral corner instability following acute knee dislocation. • Although MRI is valuable in the preoperative investigation of knee dislocation, clinical assessment and intraoperative exploration may still be required for definitive diagnosis.


Assuntos
Luxação do Joelho , Traumatismos do Joelho , Adulto , Humanos , Luxação do Joelho/diagnóstico por imagem , Traumatismos do Joelho/diagnóstico , Articulação do Joelho/diagnóstico por imagem , Imageamento por Ressonância Magnética , Masculino , Tendões
3.
Int J Lab Hematol ; 44(2): 385-392, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-34755934

RESUMO

INTRODUCTION: We aimed to evaluate the performance of the fully automated multiparameter CN-6000 hemostasis analyzer. METHODS: Performance evaluation of the CN-6000 analyzer was conducted for 10 tests including prothrombin time (PT), activated partial prothrombin time (aPTT), fibrinogen level, anti-Xa activity, and antithrombin activity using a unique portfolio of liquid ready-to-use reagents. Precision, sample and reagent carryovers, throughput, and sample turnaround time (STAT) function were prospectively assessed. Results from 343 samples (normal subjects, critically ill patients, patients receiving anticoagulants, subjects with high or low fibrinogen levels, and patients with decreased levels of factor II, V, VII, and X) were compared to those obtained on the STA-R Max 2® analyzer using dedicated reagents. RESULTS: Total precision (coefficient of variation) was below 7% for all parameters in both normal and pathological ranges. For all analyzed parameters, results obtained on the CN-6000 were strongly correlated with those obtained on the STA-R Max 2®analyzer. Agreement between both instruments was excellent for all assays. The CN-6000 demonstrated a 30% higher throughput compared to the STA-R Max 2® (258 vs 185 tests per hour for a panel of tests including PT, aPTT, fibrinogen, factor V, anti-Xa, and D-Dimer). STAT turnaround time for critical care samples testing was <7 minutes. CONCLUSIONS: The CN-6000 analyzer performs equivalently or better than the STA-R Max 2® with a significantly improved throughput. This new hemostasis multiparameter analyzer appears to be particularly well suited for coagulation laboratories which require high sample throughput and manage high numbers of nonstandard and critical care samples.


Assuntos
Hemostasia , Laboratórios , Testes de Coagulação Sanguínea/métodos , Humanos , Tempo de Tromboplastina Parcial , Tempo de Protrombina
4.
Clin Imaging ; 76: 180-188, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33957384

RESUMO

OBJECTIVES: To assess whether proximal or distal patellar tendinosis is associated with patellar maltracking parameters and superolateral Hoffa's fat pad impingement. METHODS: Institutional radiology database was reviewed for knee MRI scans performed over a 7-year period identifying cases of unequivocal patellar tendinosis, which were separated into 2 groups: proximal and distal tendinosis. For each group of proximal and distal patellar tendinosis, a control group of age and gender matched subjects was assigned. The scans were evaluated for patellar maltracking parameters including patellar alta, tibial tuberosity lateralization, trochlear dysplasia and lateral patellar tilt and for presence of superolateral Hoffa's fat pad edema. These parameters were compared between the case and control groups. RESULTS: Out of 9852 MRI scans, 94 patellar tendinosis cases were included (65 proximal and 29 distal tendinosis) and matched with equal numbers of controls. In the proximal patellar tendinosis group, more subjects had patella alta (22 versus 6, p = 0.0006), lateralization of tibial tuberosity (16 versus 7, p = 0.0495) and superolateral Hoffa's fat pad edema (16 versus 4, p = 0.0073) compared to the control group. In the distal patellar tendinosis group, there was no significant difference in the prevalence of any maltracking indicator or superolateral Hoffa's fat pad edema compared to the control group. CONCLUSION: Proximal patellar tendinosis was associated with patellar maltracking parameters including patella alta, lateralized tibial tuberosity and superolateral Hoffa's fat pad impingement. No association was demonstrated between distal patellar tendinosis and patellar maltracking indicators or superolateral Hoffa's fat pad impingement.


Assuntos
Patela , Tendinopatia , Tecido Adiposo , Estudos de Casos e Controles , Humanos , Articulação do Joelho/diagnóstico por imagem , Imageamento por Ressonância Magnética , Patela/diagnóstico por imagem , Tendinopatia/diagnóstico por imagem
5.
Skeletal Radiol ; 50(3): 597-602, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32803376

RESUMO

Initially described, in 1948, as a tumor that could be mistaken with chondrosarcoma at histopathology, chondromyxoid fibroma is now a well-recognized entity. Surface-type chondromyxoid fibroma, however, remains an extremely rare occurrence. We present a case of a 55-year-old woman, who experienced right arm pain for 5 years. After unsuccessful treatment for presumed thoracic outlet syndrome, MRI revealed a large mass abutting the anteromedial cortex of the distal humeral diaphysis in a subperiosteal location. Further characterization was made with radiography, CT, and bone scan, which were followed by ultrasound-guided biopsy. Although histopathologic features were suggestive of chondromyxoid fibroma, the diagnosis remained somewhat uncertain initially due to the very unusual location involving the diaphysis of the humerus. Surgical resection was performed, and subsequent histopathologic analysis confirmed the diagnosis of chondromyxoid fibroma. Despite being a rare entity, surface-type chondromyxoid fibroma would need to be considered in the differential when dealing with expansile surface diaphyseal lesions.


Assuntos
Neoplasias Ósseas , Condromatose , Fibroma , Neoplasias Ósseas/diagnóstico por imagem , Neoplasias Ósseas/cirurgia , Diáfises , Feminino , Fibroma/diagnóstico por imagem , Fibroma/cirurgia , Humanos , Úmero/diagnóstico por imagem , Úmero/cirurgia , Pessoa de Meia-Idade
6.
PLoS One ; 15(8): e0231685, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32760069

RESUMO

Mycobacterium ulcerans, a non-tuberculous mycobacterium responsible for Buruli ulcer, resides in poorly defined environmental niches in the vicinity of stagnant water. Very few isolates have been confirmed. With a view to culturing M. ulcerans from such contaminated environmental specimens, we tested the in vitro susceptibility of the M. ulcerans CU001 strain co-cultivated with XTC cells to anti-infectious molecules registered in the French pharmacopoeia. We used a standardised concentration to identify molecules that were inactive against M. ulcerans and which could be incorporated into a decontaminating solution. Of 116 tested molecules, 64 (55.1%) molecules were ineffective against M. ulcerans CU001. These included 34 (29.3%) antibiotics, 14 (12%) antivirals, eight (6.8%) antiparasitics, and eight (6.8%) antifungals. This left 52 molecules which were active against M. ulcerans CU001. Three of the inactive antimicrobial molecules (oxytetracycline, polymyxin E and voriconazole) were then selected to prepare a decontamination solution which was shown to respect M. ulcerans CU001 viability. These three antimicrobials could be incorporated into a decontamination solution to potentially isolate and culture M. ulcerans from environmental samples.


Assuntos
Anti-Infecciosos/análise , Mycobacterium ulcerans/crescimento & desenvolvimento , Mycobacterium ulcerans/isolamento & purificação , Úlcera de Buruli/microbiologia , Colistina , Humanos , Programas de Rastreamento , Testes de Sensibilidade Microbiana/métodos , Mycobacterium , Mycobacterium ulcerans/patogenicidade , Oxitetraciclina , Voriconazol
7.
Fundam Clin Pharmacol ; 25(6): 753-61, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21219439

RESUMO

Since several years, the use of intravenous immunoglobulins (IVIg) has increased. This growth has encouraged some countries to publish guidelines. In parallel, some countries have conducted audits to know how IVIg are used in clinical practice in the light of the available guidelines. The objective of this study was to assess IVIg use in three French university hospitals in 2006. All IVIg administrations were evaluated during 6 months (12 September 2005-12 March 2006) in French university hospitals of Marseille. Different data were recorded for each administration: patient characteristics, indication, formulation and quantity. During the study period, 2802 administrations of IVIg (corresponding to a total quantity of 76 780 g) have been recorded. Four hundred and thirty-five patients received at least one of these administrations. The five most reported indications were multifocal motor neuropathy (11.0% of total quantity), chronic inflammatory demyelinating polyradiculoneuropathy (10.2%), corticoresistant dermatomyositis (10.2%), immune thrombocytopaenia (9.9%) and primary immune deficiency (9.1%). According to available French recommendations, 70% of the IVIg use was for 'acknowledged indications', 9% for 'indications to be assessed' and 18% for 'unwarranted indications'. The 10 most reported indications were 'acknowledged indications' according to available recommendations of the French expert group. Nevertheless, the two most reported indications were not approved by the French Health Products Agency (AFSSAPS) at the time of the study and were approved since.


Assuntos
Imunoglobulinas Intravenosas/uso terapêutico , Fatores Imunológicos/uso terapêutico , Guias de Prática Clínica como Assunto , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , França , Hospitais Universitários/estatística & dados numéricos , Humanos , Lactente , Recém-Nascido , Masculino , Uso Off-Label , Padrões de Prática Médica/estatística & dados numéricos , Adulto Jovem
8.
Appl Opt ; 46(10): 1686-92, 2007 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-17356611

RESUMO

A simplified approach is proposed to simulate the fluorescence signal from a fluorophore submerged inside a turbid medium using the Monte Carlo method. Based on the reversibility of photon propagation, the fluorescence signal can be obtained from a single Monte Carlo simulation of the excitation light. This is computationally less expensive and also allows for the direct use of well-validated nonfluorescence photon migration Monte Carlo codes. Fluorescence signals from a mouse tissuelike phantom were computed using both the simplified Monte Carlo simulation and the diffusion approximation. The relative difference of signal intensity was found to be at most 30% for a fluorophore placed in the medium at various depths and horizontally midway between a source-detector pair separated by 3 mm. The difference in time characteristics of the signal is also examined.


Assuntos
Algoritmos , Aumento da Imagem/métodos , Interpretação de Imagem Assistida por Computador/métodos , Microscopia de Fluorescência/métodos , Nefelometria e Turbidimetria/métodos , Refratometria/métodos , Tomografia Óptica/métodos , Animais , Simulação por Computador , Camundongos , Microscopia de Fluorescência/instrumentação , Modelos Biológicos , Modelos Estatísticos , Método de Monte Carlo , Imagens de Fantasmas , Reprodutibilidade dos Testes , Espalhamento de Radiação , Sensibilidade e Especificidade , Tomografia Óptica/instrumentação
10.
Eur J Epidemiol ; 19(5): 453-60, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15233318

RESUMO

Mathematical models currently used to study the relationship between the prevalence of the resistance to an antibiotic and the amount of drug may not be adequate because they do not integrate temporal and area analyses simultaneously. Furthermore, the forms of such relationship are unknown. We applied the Generalized Additive Model (GAM) to study fluoroquinolone use and the incidence of fluoroquinolone-resistance in Staphylococcus aureus in our institution over a 3-year period. Overall institution and individual hospital unitrestricted analyses were performed. Relative risk (RR) observed for increasing fluoroquinolone use with a 4-month lag from the 25th percentile to the 75th percentile was 1.27 (95% CI: 1.13-1.42). In the surgery units, RR was 1.23 (95% CI: 1.01-1.50) for fluoroquinolone use with a 2-months lag. GAM enabled us to observe for the first time a significant temporal relationship between fluoroquinolone use and the incidence of fluoroquinolone-resistant nosocomial S. aureus isolates.


Assuntos
Infecção Hospitalar/tratamento farmacológico , Farmacorresistência Bacteriana , Revisão de Uso de Medicamentos/estatística & dados numéricos , Fluoroquinolonas/administração & dosagem , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/efeitos dos fármacos , Infecção Hospitalar/microbiologia , Infecção Hospitalar/prevenção & controle , Fluoroquinolonas/farmacologia , França , Unidades Hospitalares/estatística & dados numéricos , Humanos , Incidência , Tempo de Internação , Modelos Lineares , Medição de Risco , Infecções Estafilocócicas/prevenção & controle , Staphylococcus aureus/isolamento & purificação , Fatores de Tempo
11.
J Pediatr Hematol Oncol ; 25(6): 441-7, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12794521

RESUMO

PURPOSE: In a previous randomized study, the authors reported that granulocyte colony-stimulating factor (G-CSF) increased the chemotherapy dose-intensity delivered during the consolidation therapy of high-risk childhood acute lymphoblastic leukemia (ALL). The aim of the current study was to perform an economic evaluation in the same cohort. METHODS: In this open-label multicenter randomized trial, prophylactic G-CSF was administered after consolidation therapy courses. Economic data were retrospectively quantified for each patient: hospital stays, drugs, and blood products. RESULTS: Sixty-seven children were enrolled in the very high-risk branch of the FRALLE 93 protocol. Chemotherapy dose-intensity was significantly increased (105 +/- 5% in the G-CSF group vs. 91 +/- 4% in the non-G-CSF group, P < 0.001). The mean total costs per child were not statistically different: 32,309 dollars in the G-CSF group versus 31,569 dollars in the non-G-CSF group. Further analysis per child and per course (R3 or COPADM) demonstrated that the mean cost of hospitalization and the mean cost of intravenous antibiotics were significantly decreased in the G-CSF group after R3 courses (3,857 dollars vs. 4,993.80 dollars, P < 0.001; 171.40 dollars vs. 306.20 dollars, P = 0.029, respectively), but the cost of platelet transfusion was significantly increased (P = 0.03). Conversely, post-COPADM costs were similar. Finally, mean costs per course in the two randomized groups were not significantly different: 5,848.80 dollars versus 6,181 dollars and 7,388.10 dollars versus 6,475.70 dollars for R3 and COPADM, respectively. The 3-year probability of event-free survival between the two groups was not different. CONCLUSIONS: G-CSF can increase chemotherapy dose-intensity in very high-risk ALL without raising costs, but event-free survival was not improved. The cost benefit of prophylactic treatment by G-CSF relies on the chemotherapeutic regimen given prior to G-CSF administration.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/economia , Fator Estimulador de Colônias de Granulócitos/economia , Neutropenia/economia , Leucemia-Linfoma Linfoblástico de Células Precursoras/economia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Criança , Estudos de Coortes , Análise Custo-Benefício , Intervalo Livre de Doença , Farmacoeconomia , Feminino , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Humanos , Lactente , Recém-Nascido , Masculino , Neutropenia/prevenção & controle , Cuidados Paliativos/economia , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidade , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Proteínas Recombinantes , Fatores de Risco , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...